SecBot SecBot

GBIO

Generation Bio Co.
Nasdaq· Pharmaceutical Preparations· CIK 0001733294 Biotech & Drug Discovery
—
Next earnings
Nov 3
in 7 days
Insider net
$0
no open-market trades · since Feb 9
New fund stakes
0
Q4 2025 13F · 0 exits

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells since Feb 9. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q4 2025: 3 added (0 new), 5 trimmed or exited.

Who's buying

13F· Q4 2025
0
new positions
0
exits
FundMoveSharesValue
CWM, LLCNEAR_EXIT1—
PRICE T ROWE ASSOCIATES INC /MD/TRIM209,641$1.2M
MARSHALL WACE, LLPTRIM140,294$796.9K
TWO SIGMA INVESTMENTS, LPDOUBLED50,557$287.2K
NORTHERN TRUST CORPADD17,058$96.9K
FMR LLCNEAR_EXIT2,617$14.9K
Rockefeller Capital Management L.P.ADD500$2.8K
Optiver Holding B.V.TRIM2$11.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Dec 2025
Recent actions
DateFirmActionRating
Dec 16, 2025Wedbush
UPGRADE
UPGRADEOutperform
Dec 16, 2025Jefferies
DOWNGRADE
DOWNGRADEHold
Aug 18, 2025Canaccord Genuity
MAINTAIN
MAINTAINBuy
Aug 13, 2025Needham
REITERATE
REITERATEBuy
Aug 13, 2025Wedbush
DOWNGRADE
DOWNGRADENeutral
May 8, 2025Needham
REITERATE
REITERATEBuy

Insider ledger

Form 4
$0
open-market buys or sells · since Feb 9
DateInsiderTypeValue
Feb 9, 2026
Rhodes Jason P
Director
TO ISSUER2,500 sh
Feb 9, 2026
Christensen Gustav
Director
TO ISSUER1,500 sh
Feb 9, 2026
Rhodes Jason P
Director
TO ISSUER1,920 sh
Feb 9, 2026
Quinn Anthony G.
Director
TENDER29,928 sh
Feb 9, 2026
Quinn Anthony G.
Director
TO ISSUER2,500 sh
Feb 9, 2026
Quinn Anthony G.
Director
TO ISSUER3,000 sh
Feb 9, 2026
Rhodes Jason P
Director
TO ISSUER3,000 sh
Feb 9, 2026
Rhodes Jason P
Director
TO ISSUER1,500 sh
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 10, 2026 Earnings calendar
GBIO Q2 2026 Earnings Scheduled — 2026-08-10
Feb 9, 2026 Insider
Rhodes Jason P disposed of 2,500 shares
Director
Feb 9, 2026 Insider
Christensen Gustav disposed of 1,500 shares
Director
Feb 9, 2026 Insider
Rhodes Jason P disposed of 1,920 shares
Director
Dec 31, 2025 Inst.
CWM, LLC — NEAR_EXIT
1 shares (—)
Dec 31, 2025 Inst.
PRICE T ROWE ASSOCIATES — TRIM
209,641 shares ($1.2M)